144 related articles for article (PubMed ID: 7295483)
1. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
Muir AL; Hannan WJ; Dewhurst NG; Slessor IM
Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483
[TBL] [Abstract][Full Text] [Related]
2. Can right ventricular performance be assessed by equilibrium radionuclide ventriculography?
Xue QF; MacNee W; Flenley DC; Hannan WJ; Adie CJ; Muir AL
Thorax; 1983 Jul; 38(7):486-93. PubMed ID: 6137086
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
Klein W; Brandt D; Maurer E
Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of prenalterol in patients with coronary heart disease.
Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
7. The hemodynamic actions of prenalterol in left ventricular failure.
Awan NA; Evenson MK; Needham KE; Mason DT
Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
[TBL] [Abstract][Full Text] [Related]
8. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
[TBL] [Abstract][Full Text] [Related]
9. Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation.
Branzi A; Specchia S; Binetti G; Magelli C; Zannoli R; Magnani B
Eur Heart J; 1983 Apr; 4(4):252-8. PubMed ID: 6684041
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
Kupper W; Schütt M; Bleifeld W
Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
[TBL] [Abstract][Full Text] [Related]
11. Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
Boström PA; Andersson J; Johansson BW; Lilja B; Thorell J; Tidfält K; Westerling S
Eur J Clin Invest; 1984 Jun; 14(3):175-80. PubMed ID: 6147253
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the hemodynamic effects of prenalterol and isoprenaline in patients with complete heart block.
Svendsen TL; Pelle H; Lønholt C; Bonde J; Kampmann JP; Lindeneg O
J Cardiovasc Pharmacol; 1984; 6(4):693-6. PubMed ID: 6206327
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
Shiu MF; Ireland MA; Littler WA
Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
[TBL] [Abstract][Full Text] [Related]
14. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
Currie PJ; Kelly MJ; Middlebrook K; Federman J; Sainsbury E; Ashley J; Pitt A
Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
[TBL] [Abstract][Full Text] [Related]
15. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
Awan NA; Needham KE; Evenson MK; Win A; Mason DT
Am Heart J; 1981 Feb; 101(2):158-61. PubMed ID: 7468416
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
[TBL] [Abstract][Full Text] [Related]
18. Effects of prenalterol administered orally in patients with congestive heart failure.
Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent haemodynamic response to prenalterol in patients with congestive heart failure.
Leinberger H; Mäurer W; Haueisen H; Schuler G; Kübler W
Acta Med Scand Suppl; 1982; 659():299-306. PubMed ID: 6127896
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
Hutton I; Tweddel AC; Bastian BC; Murray RG
Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
